Avenue Therapeutics, Inc.

ATXI

Exchange: OTC
Industry: Pharmaceutical Preparations
SEC CIK: 0001644963

SEC filings (opens in a new tab)

No open-market purchases or sales by Avenue Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Avenue Therapeutics, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of ATXI: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	12	14	+2
Shares	727.7K	222.7K	−504.9K (−69.4%)
Value	$849.4K	$157.3K	−$692.1K (−81.5%)

New holders (3)

Institutions that held Avenue Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ATXI in Q3 2023
Institution	Shares	Value	% of portfolio
Vanguard Group Inc	46,293	$32.7K	0.00%
Two Sigma Securities, LLC	14,438	$10.2K	0.00%
Advisor Group Holdings, Inc.	500	$353	0.00%

Sold out (1)

Institutions that held Avenue Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of ATXI in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Sabby Management, LLC	553,338	$647.4K